Active Ingredient (In Each 30 Ml)
Sennosides 8.6mg
The following Structured Product Label (SPL) was submitted to the FDA by Allegiant Health for the product Senna Lax (NDC 69168-371). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each 30 ml), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of childen., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Sennosides 8.6mg
Laxative
laxative products for longer than one week unless directed by a doctor
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of accidental overdose, contact a doctor or Poison Control Center (1-800-222-1222) right away.
| age | starting Dosage | maximum Dosage |
| adults and children 12 years of age and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | ½ tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
croscarmellose sodium, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide
* Please review the disclaimer below.